Diagnostic Biomarkers Exploration of Breast Cancer From Serum and Urine

Launched by SUN YAT-SEN MEMORIAL HOSPITAL OF SUN YAT-SEN UNIVERSITY · Oct 20, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how to find specific markers in blood and urine that can help diagnose breast cancer in women. Researchers want to compare these markers between women with breast cancer, those with non-cancerous conditions, and healthy individuals. The ultimate goal is to create a smart diagnostic tool using machine learning, which is a type of technology that helps analyze data and identify patterns, to better distinguish between breast cancer and non-breast cancer patients.

To participate in this trial, women aged between 18 and 75 who have been diagnosed with a breast mass and are planning to have surgery may be eligible. Participants will be asked to provide blood and urine samples during their treatment, and these samples will be collected in a way that does not interfere with their medical care. It's important to note that participants must not have other types of cancer and should be in reasonable health, as determined by their doctors. This study is currently looking for volunteers, and being part of it could help improve breast cancer diagnosis for future patients.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Signing the consent of informedness;
• • 2. Patients with breast mass who need surgery after examination;
• • 3. Cardiac ultrasound indicates that the blood score of the heart is within the normal range;
• • 4. ECOG≤0-2 points;
• • 5. Oversure function is acceptable.
• Exclusion Criteria:
• • 1. Merge other malignant tumors such as gynecologic oncology;
• • 2. After evaluation, the internal organs are not suitable.